These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2515880

  • 1. Serum thymidine kinase--a marker of bone marrow toxicity during treatment with zidovudine.
    Pedersen C, Ingeberg S, Teglbjaerg LS.
    AIDS; 1989 Nov; 3(11):743-6. PubMed ID: 2515880
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS.
    N Engl J Med; 1987 Jul 23; 317(4):192-7. PubMed ID: 3299090
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum thymidine kinase (TK) evaluation in HIV infection.
    Sabbatani S, Fini A, Raise E, Gritti FM.
    Int J Biol Markers; 1989 Jul 23; 4(1):40-4. PubMed ID: 2746046
    [Abstract] [Full Text] [Related]

  • 7. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
    Skowron G, Bozzette SA, Lim L, Pettinelli CB, Schaumburg HH, Arezzo J, Fischl MA, Powderly WG, Gocke DJ, Richman DD, Pottage JC, Antoniskis D, McKinley GF, Hyslop NE, Ray G, Simon G, Reed N, LoFaro ML, Uttamchandani RB, Gelb LD, Sperber SJ, Murphy RL, Leedom JM, Grieco MH, Zachary J, Hirsch MS, Spector SA, Bigley J, Soo W, Merigan TC.
    Ann Intern Med; 1993 Mar 01; 118(5):321-30. PubMed ID: 8094279
    [Abstract] [Full Text] [Related]

  • 8. Zidovudine treatment of AIDS and ARC in Denmark 1987.
    Teglbjaerg LL, Mathiesen LR, Søeberg B, Nielsen L, Thorsen B, Buhl M, Pedersen C, Bonnevie O, Nielsen C, Vestergaard BF.
    Scand J Infect Dis; 1989 Mar 01; 21(4):367-73. PubMed ID: 2685984
    [Abstract] [Full Text] [Related]

  • 9. Zidovudine and other drugs against HIV.
    Drug Ther Bull; 1988 Dec 28; 26(26):101-4. PubMed ID: 3065024
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD.
    Ann Intern Med; 1990 May 15; 112(10):727-37. PubMed ID: 1970466
    [Abstract] [Full Text] [Related]

  • 13. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW, Cooper DA, Mathiesen L, Sandström E, Clumeck N, Gatell JM, French M, Donovan B, Gray F, Yeo JM.
    AIDS; 1994 Mar 15; 8(3):313-21. PubMed ID: 7913326
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum thymidine kinase in AIDS patients treated with zidovudine.
    Pedersen C, Ingeberg S.
    Lancet; 1987 Aug 22; 2(8556):460. PubMed ID: 2887768
    [No Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group.
    Cooper DA, Pedersen C, Aiuti F, Vilde JL, Ruhnke M, Pehrson PO, Clumeck N, Farthing C, Lüthy R, Doherty RR.
    AIDS; 1991 Aug 22; 5(8):933-43. PubMed ID: 1777174
    [Abstract] [Full Text] [Related]

  • 17. Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine.
    Connolly KJ, Allan JD, Fitch H, Jackson-Pope L, McLaren C, Canetta R, Groopman JE.
    Am J Med; 1991 Nov 22; 91(5):471-8. PubMed ID: 1659189
    [Abstract] [Full Text] [Related]

  • 18. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE, Leuther MD, Allain JP, Nusinoff-Lehrman S, Boone GS, Feigal D, Volberding P.
    Arch Intern Med; 1988 Oct 22; 148(10):2151-3. PubMed ID: 3263098
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.